project id: TCGA-UCEC; case submitter id: TCGA-AX-A3G8; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 9.5; age at index: 76; days to birth: -27899; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1934; age at diagnosis: 27899; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 36.0; figo stage: Stage IA; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 350; initial weight: 110.0; oct embedded: false; preservation method: Unknown; sample id: dfe35835-d03e-4ce3-a76a-fdb15e601257; sample submitter id: TCGA-AX-A3G8-01A; portion id: bf25511d-d297-4fd3-badd-dd68bbce8c00; portion submitter id: TCGA-AX-A3G8-01A-11; slide id: 353f1c27-91b6-40bf-a5b3-e8b1abcc2d59; slide submitter id: TCGA-AX-A3G8-01A-01-TS1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 2.0; percent tumor cells: 96.0; percent tumor nuclei: 97.0; section location: TOP;